BRPI0910873A2 - análogos antagonistas de gh-rh substituídos nos terminais n e c - Google Patents

análogos antagonistas de gh-rh substituídos nos terminais n e c

Info

Publication number
BRPI0910873A2
BRPI0910873A2 BRPI0910873A BRPI0910873A BRPI0910873A2 BR PI0910873 A2 BRPI0910873 A2 BR PI0910873A2 BR PI0910873 A BRPI0910873 A BR PI0910873A BR PI0910873 A BRPI0910873 A BR PI0910873A BR PI0910873 A2 BRPI0910873 A2 BR PI0910873A2
Authority
BR
Brazil
Prior art keywords
terminal substituted
antagonist analogs
antagonist
analogs
substituted
Prior art date
Application number
BRPI0910873A
Other languages
English (en)
Portuguese (pt)
Inventor
Andrew V Schally
Jozsef L Varga
Marta Zarandi
Ren Zhi Cai
Original Assignee
Us Of America Represented By The Dept Of Veterans Affairs
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Of America Represented By The Dept Of Veterans Affairs, Univ Miami filed Critical Us Of America Represented By The Dept Of Veterans Affairs
Publication of BRPI0910873A2 publication Critical patent/BRPI0910873A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0910873A 2008-03-28 2009-03-26 análogos antagonistas de gh-rh substituídos nos terminais n e c BRPI0910873A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4041808P 2008-03-28 2008-03-28
PCT/US2009/038351 WO2009120831A2 (en) 2008-03-28 2009-03-26 Novel n-and c-terminal substituted antagonistic analogs of gh-rh

Publications (1)

Publication Number Publication Date
BRPI0910873A2 true BRPI0910873A2 (pt) 2015-10-06

Family

ID=40886425

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910873A BRPI0910873A2 (pt) 2008-03-28 2009-03-26 análogos antagonistas de gh-rh substituídos nos terminais n e c

Country Status (11)

Country Link
US (1) US8227405B2 (https=)
EP (1) EP2288374B1 (https=)
JP (1) JP5588963B2 (https=)
CN (1) CN101983068B (https=)
AU (1) AU2009228244A1 (https=)
BR (1) BRPI0910873A2 (https=)
CA (1) CA2718146C (https=)
IL (1) IL208099A0 (https=)
MX (1) MX2010010642A (https=)
WO (1) WO2009120831A2 (https=)
ZA (1) ZA201006843B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691942B2 (en) * 2008-03-28 2014-04-08 University Of Miami N- and C- terminal substituted antagonistic analogs of GH-RH
US8227421B2 (en) * 2009-09-17 2012-07-24 University Of Miami Fluorinated GHRH antagonists
WO2011153491A2 (en) 2010-06-03 2011-12-08 University Of Miami Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
US9079974B2 (en) 2011-12-21 2015-07-14 The University Of Miami GH-RH analogs with potent agonistic effects
EP2866894A4 (en) * 2012-06-27 2016-03-16 Univ Miami COMPOSITION AND METHOD FOR THE TREATMENT OF MORBUS ALZHEIMER
WO2014100816A2 (en) 2012-12-21 2014-06-26 University Of Miami Ghrh agonists for islet cell transplantation and function and the treatment of diabetes
WO2014100809A2 (en) 2012-12-21 2014-06-26 University Of Miami Ghrh agonists for the treatment of ischemic disorders
AU2020218272A1 (en) * 2019-02-08 2021-09-02 United States Government As Represented By The Department Of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof
WO2021011874A1 (en) 2019-07-18 2021-01-21 University Of Miami Ghrh antagonists for use in a method of treating sarcoidosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0527914A4 (en) * 1990-05-04 1993-08-11 The Administrators Of The Tulane University Educational Fund Novel synthetic grf analogs
US5942489A (en) * 1996-05-03 1999-08-24 The Administrators Of The Tulane Educational Fund HGH-RH(1-29)NH2 analogues having antagonistic activity
US6057422A (en) * 1998-11-25 2000-05-02 The Administrators Of The Tulane Educational Fund Antagonistic analogs of GH-RH inhibiting IGF-I and -II
TW200517400A (en) * 2003-08-05 2005-06-01 Univ Tulane Antagonistic analogs of GH-RH (2003)
US8227421B2 (en) * 2009-09-17 2012-07-24 University Of Miami Fluorinated GHRH antagonists

Also Published As

Publication number Publication date
US8227405B2 (en) 2012-07-24
IL208099A0 (en) 2010-12-30
EP2288374A2 (en) 2011-03-02
CN101983068A (zh) 2011-03-02
WO2009120831A8 (en) 2010-09-30
US20100092539A1 (en) 2010-04-15
EP2288374B1 (en) 2017-02-01
CN101983068B (zh) 2014-12-24
CA2718146C (en) 2016-09-20
CA2718146A1 (en) 2009-10-01
AU2009228244A1 (en) 2009-10-01
ZA201006843B (en) 2012-03-28
WO2009120831A2 (en) 2009-10-01
MX2010010642A (es) 2011-03-29
WO2009120831A3 (en) 2009-12-23
JP5588963B2 (ja) 2014-09-10
JP2011517675A (ja) 2011-06-16

Similar Documents

Publication Publication Date Title
FR22C1020I2 (fr) Antagonistes de c5ar
BRPI0910592A2 (pt) antagonistas de receptor 2 de somatostatina
BRPI0910118A2 (pt) antagonistas de receptores do glucagon
BRPI0823379A2 (pt) Análogos de glucagon
BRPI0823377A2 (pt) análogos de glucagon
BRPI0823378A2 (pt) análogos de glucagon
BRPI0823376A2 (pt) Análagos de glucagon
EP2350060A4 (en) Melanocortin receptor AGONISTS
BRPI0910873A2 (pt) análogos antagonistas de gh-rh substituídos nos terminais n e c
DK2443104T3 (da) Disubstituerede phthalazin-hedgehog-sti-antagonister
DK2252581T3 (da) Kappa-selektiv opioidreceptorantagonist
EP2266026A4 (en) EFFICIENT DETERMINIST MULTIPLE PROCESSING
PT2315781E (pt) Antagonistas específicos do recetor fgf-r4
BRPI0923512A2 (pt) antagonistas de receptores de ácido lisofosfatídico
BRPI0907885A2 (pt) Compostos antiviras hetrocíclicos
BRPI0911269A2 (pt) análogos de halicondrina b
HRP20151108T1 (xx) Antagonisti nogo-receptora
BRPI1016189A2 (pt) compostos de 4-azetidinil-1-fenil-ciclohexano antagonistas de ccr2
BRPI0918004A2 (pt) antagonistas de glucagon
BRPI0810926A2 (pt) Antagonista de crig
HRP20150167T1 (xx) Spojevi kao antagonisti bradikinina-b1
BR112012003701A2 (pt) "novos antagonistas de quinolina-hepcidina"
BRPI0907122A2 (pt) Piridoindóis (1-azinona) substituídos
EP2518110A4 (en) COMPOSITION AND COMPOSITION USING LIGHT-EMITTING ITEM
EP2483300A4 (en) SYNTHETIC MYOSTATINPEPTIDE ANTAGONISTS

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.